ArticleThoracic cancer2021

Interstitial lung disease associated with capmatinib therapy in a patient with non-small cell lung cancer harboring a skipping mutation of MET exon 14.

Hiroaki Kanemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.